Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06734260

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection:a Multicenter, Prospective, Randomized Controlled Study

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
477 (estimated)
Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Eradication of HP can significantly improve and reduce HP-related diseases. A 10-14 day quadruple regimen containing bismuth as first-line treatment, achieving an eradication rate of more than 85%. However, some disadvantages of these quadruple regimens, such as severe adverse reactions, high medical costs and low compliance, prevent their application in clinical practice. High-dose proton pump inhibitors (PPI) combined with amoxicillin can be used as the first-line treatment for HP eradication, with good efficacy and compliance and low rate of adverse reactions. However, the acid inhibition effect of PPI mainly depends on the degree of individual metabolism of proton pump,which might influence the eradication effect. Keverprazan, a new competitive potassium acid blocker(P-CAB), is not affected by gene polymorphism, and has the advantage of stronger and longer inhibition effect on gastric acid compared with PPIs. This study aimed to evaluate two different doses of therapy (1 g b.i.d. vs. 1.0 g t.i.d.) and two different durations of therapy (14 vs.10 days) to gain insights of the effectiveness of Keverprazan-amoxicillin dual therapy .

Conditions

Interventions

TypeNameDescription
DRUGKeverprazan Hydrochloride tablets + high dose amoxicillinKeverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 14 day
DRUGKeverprazan Hydrochloride tablets + low dose amoxicillinKeverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 2 times/day, oral, for 14 day
DRUGKeverprazan Hydrochloride tablets + high dose amoxicillin(H-KA-10d)Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 10 day

Timeline

Start date
2024-09-10
Primary completion
2025-11-10
Completion
2026-01-10
First posted
2024-12-16
Last updated
2025-12-05

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06734260. Inclusion in this directory is not an endorsement.